Table 5 Regional network differences between erenumab responders and non-responders at 8 weeks after the first erenumab treatment. Shown for all uncorrected p-values of 0.05 or less. Numbers in parentheses are standard deviations. Inf = inferior; Lat = lateral

From: Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab